Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission
US6060065A · kind A · utility
36Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | May 9, 2000 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to viral peptides referred to as "DP107- and DP178-like" peptides. Specifically, the invention relates to isolated influenza A DP107- and DP178-like peptides which are identified by sequence search motif algorithms. The peptides of the invention exhibit antiviral activity believed to result from inhibition of viral induced fusogenic events.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.